The SSPC mission is "to position Ireland as a global hub for process innovation and advanced manufacturing in the pharmaceutical industry". SSPC vision is to be "recognised as the leading centre of excelence shaping the future of global pharmaceuticals".
The SSPC transcends company and academic boundaries and is the largest research collaboration in Ireland, and one of the largest globally, within the pharmaceutical area. The SSPC supports over 300 active members, across academia and industry on a national and international basis.
Launched in July 2013, the Synthesis and Solid State Pharmaceutical Centre (SSPC), supporting 90 top-class researchers, is the largest research collaboration in Ireland, and one of the largest globally, within the pharmaceutical area. The SSPC represents a significant combined Science Foundation Ireland and industry investment of €42 million. Building upon the success of the Cluster (2007-2013), the SSPC research programme now spans the entire pharmaceutical production chain from synthesis of the molecule, to the isolation of the material, and the formulation of the medicine. In other words, the SSPC research programme focuses upon developing more environmentally sustainable methods for drug manufacturing; increasing the range of medicines available to the public; and reducing drug manufacturing costs.
Perceptive is proud to play a role in the continuing success of the SSPC, by providing our PharmaMV software platform alongside practical industrial knowledge of scale-up and process optimisation.
Our Clients & Partners
Selection of our clients and key partners we work with to improve process efficiency
Throughout development to manufacturing, data is key to enable rapid response to market demand. The knowledge to enable intelligent decisions and the wisdom to optimise the complete product lifecycle is now at your fingertips. The latest release of PerceptiveAPC v8.0 delivers the next
PD2M May 18-20 2021 Virtual This is the place to explore what pharmaceutical manufacturing will look like in 2030, sharing discussions on new ways to develop medicines. How will Industry 4.0 enable us to respond to market demand, delivering flexible, modular manufacturing and bringing
18-19 May 2021 Virtual Perceptive Engineering - an Applied Materials company - is looking forward to participating in the Bionow Pharma Manufacturing Conference 2021. We will be joining AstraZeneca and Bristol Meyers Squibb in session 2, discussing the ‘Digitisation of Pharma